. Author manuscript; available in PMC: 2015 Apr 1.

Published in final edited form as: Am J Hematol. 2014 Mar 7;89(4):395–398. doi: 10.1002/ajh.23655

Table 1.

Patient characteristics and univariate analysis of factors associated with differences in the groups of study

Parameter		AHSCT group N(%)/Median [range]	Salvage chemotherapy group N(%)/Median [range]	P-value
		N=28	N=149
Age (years)		56 [20–77]	61 [18–85]	0.014
Bone marrow blasts percentage		19 [0–82]	41[0–94]	0.003
WBC (× 10⁹/L)		2.0 [0.5–6.5]	2.4 [0.1–97.0]	0.113
Platelets (× 10⁹/L)		55 [4–317]	27 [1–1105]	0.119
Cytogenetics	−5/−7	6 (21)	54 (36)	0.014
	Diploid	7 (25)	43 (29)
	Others	15 (54)	52 (35)
Gender	Female	14 (50)	58 (39)	0.027
	Male	14 (50)	91 (61)	0.027
AHD		14 (50)	80 (54)	0.719
Prior chemotherapy/radiation		6 (21)	29(19)	0.810
FLT3 status	Mutated	2 (7)	18 (12)	0.587
	Wild type	10 (36)	60 (40)
	Not performed	16 (57)	71 (48)

AHD= antecedent of hematologic disorder; WBC= white blood cell; AHSCT= Allogeneic hematopoietic stem cell transplantation